LEUKODYSTROPHY, HYPOMYELINATING, 9
|
disease |
|
Disease or Syndrome
|
1
|
8
|
0.700 |
strong |
1.000 |
3 |
8
|
2014 |
2017 |
Haematopoietic neoplasms (excl leukaemias and lymphomas)
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Refractory cytopenia with multilineage dysplasia (RCMD)
|
disease |
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
< 0.001 |
1 |
|
2010 |
2010 |
Absent smooth pursuit
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Myelodysplastic syndrome, no ICD-O subtype
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
4
|
19
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Pontocerebellar Hypoplasia Type 6
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome; Congenital Abnormality
|
5
|
13
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Secondary acquired sideroblastic anemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
6
|
2
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
spinal cord involvement
|
disease |
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Progressive extrapyramidal movement disorder
|
phenotype |
|
Finding
|
9
|
|
0.100 |
None |
|
0 |
|
|
|
secondary myelodysplastic syndromes
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
Refractory cytopenia with multilineage dysplasia
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
11
|
1
|
0.010 |
None |
< 0.001 |
1 |
|
2010 |
2010 |
Pseudobulbar Palsy
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
13
|
|
0.100 |
None |
|
0 |
|
|
|
Developmental stagnation
|
phenotype |
|
Finding
|
14
|
2
|
0.100 |
None |
|
0 |
|
|
|
Hyperintensity of cerebral white matter on MRI
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
15
|
1
|
0.100 |
None |
|
0 |
|
|
|
Infantile axial hypotonia
|
phenotype |
|
Finding
|
17
|
8
|
0.100 |
None |
|
0 |
|
|
|
Lower limb hypertonia
|
phenotype |
|
Finding
|
21
|
5
|
0.100 |
None |
|
0 |
|
|
|
Cerebral hypomyelination
|
phenotype |
|
Finding
|
29
|
6
|
0.400 |
None |
1.000 |
1 |
|
2014 |
2014 |
Pelizaeus-Merzbacher Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
30
|
30
|
0.010 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Diffuse cerebral atrophy
|
phenotype |
Nervous System Diseases; Mental Disorders
|
Finding
|
34
|
2
|
0.100 |
None |
|
0 |
|
|
|
Refractory anemia with ringed sideroblasts
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
36
|
3
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2016 |
Refractory anemia, without ringed sideroblasts, without excess blasts
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
38
|
2
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2015 |
Myelodysplastic-Myeloproliferative Diseases
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
38
|
1
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Myelodysplastic Syndrome with Isolated del(5q)
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
41
|
1
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2008 |
Chromosome 5, trisomy 5q
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
42
|
1
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2008 |